Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Roche's emicizumab shows substantial reduction in bleeds in phase III studies Roche’s haemophilia A drug emicizumab has showed a significant effect in the phase III Haven 1 and Haven 2 studies. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Tiziana launches phase IIa trial of milciclib in HCC patients
Tiziana Life Sciences has started enrolling of patients in its phase IIa clinical trial with cyclin-dependent kinases (CDKs) inhibitor milciclib in patients with refractory hepatocellular carcinoma (HCC).
Contract Research & Services > Clinical Trials > News
Vertex reports positive data from cystic fibrosis trials
Vertex Pharmaceuticals has reported positive data from Phase 1 and Phase 2 trials of three different triple combination regimens in cystic fibrosis (CF) patients who have one F508del mutation and one minimal function mutation (F508del/Min).
Contract Research & Services > Clinical Trials > News

Contract Research

Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology
Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Contract Research & Services > Contract Research > News
Erytech, Queen’s University to advance eryminase program
Erytech Pharma and the Queen’s University in Canada have entered into a research collaboration to advance the preclinical development of the former’s eryminase program specifically for the treatment of arginase-1 deficiency.
Contract Research & Services > Contract Research > News

Contract Services

Sunovion to sell asthma and allergy products to Covis Pharma
Sunovion Pharmaceuticals has agreed to sell the US market rights to its ciclesonide products Alvesco (ciclesonide) Inhalation Aerosol, Omnaris (ciclesonide) Nasal Spray, and Zetonna (ciclesonide) Nasal Aerosol to Covis Pharma.
Contract Research & Services > Contract Services > News
Emergent BioSolutions to buy Sanofi’s smallpox vaccine business for $125m
By PBR Staff Writer
Emergent BioSolutions has agreed to acquire Sanofi’s smallpox vaccine business for around $125m.
Contract Research & Services > Contract Services > News